Literature DB >> 7136498

Age at onset, initial symptomatology and the course of multiple sclerosis.

S Poser, N E Raun, W Poser.   

Abstract

Entities:  

Mesh:

Year:  1982        PMID: 7136498     DOI: 10.1111/j.1600-0404.1982.tb06856.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


× No keyword cloud information.
  23 in total

Review 1.  [Differential diagnosis of chronic inflammatory diseases of the central nervous system. Cerebrospinal fluid diagnosis and immunological parameters].

Authors:  D Reske; H-F Petereit
Journal:  Nervenarzt       Date:  2004-10       Impact factor: 1.214

Review 2.  Benign multiple sclerosis: does it exist?

Authors:  Jorge Correale; María C Ysrraelit; Marcela P Fiol
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

3.  Cyclophosphamide treatment in active multiple sclerosis.

Authors:  Enrique Gómez-Figueroa; Efrain Gutierrez-Lanz; Alonso Alvarado-Bolaños; Adriana Casallas-Vanegas; Christian Garcia-Estrada; Indhira Zabala-Angeles; Arturo Cadena-Fernandez; Rivas-Alonso Veronica; Treviño-Frenk Irene; José Flores-Rivera
Journal:  Neurol Sci       Date:  2021-01-16       Impact factor: 3.307

Review 4.  Multiple sclerosis in the elderly patient.

Authors:  Amer Awad; Olaf Stüve
Journal:  Drugs Aging       Date:  2010-04-01       Impact factor: 3.923

5.  eae36, a locus on mouse chromosome 4, controls susceptibility to experimental allergic encephalomyelitis in older mice and mice immunized in the winter.

Authors:  Cory Teuscher; R W Doerge; Parley D Fillmore; Elizabeth P Blankenhorn
Journal:  Genetics       Date:  2005-11-19       Impact factor: 4.562

6.  Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events.

Authors:  M Trojano; C Avolio; C Manzari; A Calò; F De Robertis; G Serio; P Livrea
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-03       Impact factor: 10.154

Review 7.  Managing advanced multiple sclerosis.

Authors:  R W Teasell
Journal:  Can Fam Physician       Date:  1993-05       Impact factor: 3.275

8.  Clinical characteristics of patients with late-onset multiple sclerosis.

Authors:  Bernhard Kis; Bastian Rumberg; Peter Berlit
Journal:  J Neurol       Date:  2008-02-19       Impact factor: 4.849

9.  Cerebrospinal fluid in multiple sclerosis: relationships between immunoglobulins, leucocytes and clinical features.

Authors:  R W Walker; E J Thompson; W I McDonald
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

10.  Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis.

Authors:  M K Sharief; E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.